Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

755 POSTS

Exclusive articles:

SKN | ECST Holdings Expands IPO by 244% Ahead of Nasdaq Debut

Hong Kong-based enterprise software provider ECST Holdings has significantly increased the size of its planned U.S. initial public offering, signaling growing investor interest ahead...

SKN | Wilco 63 Corporation Units: SPAC Structure Returns as Market Tests Risk Appetite

Wilco 63 Corporation Units enters the IPO market as a unit-based SPAC offering aimed at identifying acquisition opportunities across technology, industrial services, and growth-oriented...

SKN | First Carolina Financial Services, Inc.: Regional Banking IPO Tests Small-Cap Financial Appetite

First Carolina Financial Services, Inc. is preparing for a public market entry that reflects renewed, but highly selective, investor interest in regional banking IPOs....

SKN | uniQure Shares Soar Nearly 80% as Gene Therapy Portfolio Drives Investor Enthusiasm

uniQure N.V. (NASDAQ: QURE) delivered one of the most significant gains in the biotechnology sector this week, with shares surging 78.44% over the past...

SKN | Cantor Equity Partners VII Raises $250 Million in Nasdaq SPAC IPO

Cantor Fitzgerald Launches Its Sixteenth SPAC Cantor Equity Partners VII has successfully priced its initial public offering, raising $250 million as the latest special purpose...

Breaking

SKN | Gores Holdings XI Raises $312 Million IPO as Veteran SPAC Sponsor Bets on Next Acquisition Opportunity

Gores Holdings XI, the latest special purpose acquisition company...

SKN | CopperTech Metals Targets $400 Million IPO as Copper Demand Surges from AI and Global Electrification

CopperTech Metals, a newly established copper and cobalt producer...

SKN | Oruka Therapeutics Surges as Investors Bet on Next-Generation Psoriasis Treatments

Oruka Therapeutics has emerged as one of biotechnology's standout...

SKN | Apogee Therapeutics Surges Nearly 47% as Investors Bet on Next-Generation Immunology Treatments

Apogee Therapeutics has captured Wall Street’s attention after its...
spot_imgspot_img